Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide Regimens in Juvenile SLE Nephritis
NCT00336414Phase 3Withdrawn
- Sponsor
- Istituto Giannina Gaslini
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide in lupus nephritis (LN), sponsored by Istituto Giannina Gaslini. Planned start Jun 2006; status: withdrawn.
02
Drugs
cyclophosphamide
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00336414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336414.